PMID: 6161204Jan 1, 1981Paper

Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a

The Journal of Experimental Medicine
T J Williams, P J Jose

Abstract

Intradermal injection of zymosan into nonsensitized rabbits induces plasma exudation, which is dependent on two mediators: C5a generated in extravascular tissue fluid and a vasodilator prostaglandin generated from substrates localized in cell membranes. This relationship between the complement system and the prostaglandin synthesis system had not previously been explored, and complement activation has generally been associated with increased vascular permeability via histamine release. We report that C5a increases vascular permeability by a mechanism that is not dependent on histamine release; however plasma exudation is virtually undetectable in the absence of a vasodilator substance. Because the permeability-increasing activity is stable in plasma, analogy with other species suggests that the activity is a result of C5a devoid of its carboxyl terminal arginine (C5a des Arg). This relates the observed permeability-increasing activity with effects on leukocytes rather than effects as an anaphylatoxin.

References

Mar 1, 1979·British Journal of Pharmacology·T J Williams
Dec 8, 1977·Nature·T J Williams, M J Peck
Aug 1, 1978·British Journal of Pharmacology·M A Bray, D Gordon
Dec 1, 1970·The Journal of Clinical Investigation·V A Bokisch, H J Müller-Eberhard
Feb 1, 1968·The Journal of Experimental Medicine·C G Cochrane, H J Müller-Eberhard
May 1, 1968·Biochemical Pharmacology·W Vogt

❮ Previous
Next ❯

Citations

Mar 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M RampartA G Herman
Aug 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A O OluyomiK Vosbeck
Dec 17, 1982·Pharmaceutisch Weekblad. Scientific Edition·F P Nijkamp, J M Sitsen
Oct 1, 1986·Agents and Actions·T J WilliamsP J Jose
Aug 1, 1983·Agents and Actions·H Bult, A G Herman
Oct 18, 1994·Biochemical Pharmacology·A AhluwaliaR J Flower
Apr 6, 1988·Journal of Immunological Methods·K BerghK Aasbakk
Dec 1, 1984·Immunopharmacology·R HueyT E Hugli
Oct 1, 1987·Immunopharmacology·F MarceauT E Hugli
Oct 1, 1985·Veterinary Immunology and Immunopathology·N Craven, M R Williams
Jan 1, 1983·International Journal of Immunopharmacology·J F Regal, R J Pickering
Jan 1, 1988·International Journal of Immunopharmacology·W EnglbergerM J Parnham
Jan 21, 2004·Cancer Letters·Chi-Li KuoTsung-Yun Liu
Dec 16, 1998·European Journal of Pharmacology·A A SteilS Jancar
Feb 9, 2000·Toxicon : Official Journal of the International Society on Toxinology·A L de AraújoC Bon
Jan 21, 1984·Lancet·J MorleyC P Page
May 12, 2001·Burns : Journal of the International Society for Burn Injuries·B Latha, M Babu
Dec 13, 2003·Journal of Pharmacological and Toxicological Methods·Felicity N E Gavins, Bristi E Chatterjee
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·J OlweusF Lund-Johansen
Dec 1, 1994·Journal of Veterinary Pharmacology and Therapeutics·P C MillsD E Auer
Jun 1, 1992·British Journal of Pharmacology·M J ForrestD E MacIntyre
Jul 1, 1992·British Journal of Pharmacology·A AhluwaliaR J Flower

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.